person

Ingrid L.

Country
Belgium
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 66 partner sites.

Specializations

Solid Tumor Oncology

Focused on the investigation of therapeutic strategies for major epithelial cancers, including hormone‑responsive and HER2‑negative disease subtypes.

  • breast cancer
  • non‑small cell lung cancer
  • colorectal carcinoma
  • head and neck squamous cell carcinoma
  • medulloblastoma

Research emphasizes targeted agents, endocrine modulators, and novel immunotherapies to improve disease‑free survival.

Hematologic Malignancies

Dedicated to the treatment of blood‑derived cancers, with particular attention to pediatric and adult acute leukemias.

  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • lymphoblastic lymphoma
  • multiple myeloma
  • Ewing sarcoma

Efforts include combination chemotherapy, kinase inhibition, and immunotherapeutic approaches to enhance remission rates.

Neuromuscular & Neurodegenerative Disorders

Investigates disease‑modifying therapies for inherited muscle diseases and motor neuron degeneration.

  • Duchenne muscular dystrophy
  • Becker muscular dystrophy
  • spinal muscular atrophy
  • amyotrophic lateral sclerosis
  • Charcot‑Marie‑Tooth disease

Key initiatives target gene‑replacement, exon‑skipping, and neuroprotective agents.

Cardiovascular & Metabolic Medicine

Addresses acute and chronic heart conditions, arrhythmias, and related metabolic risk factors.

  • acute coronary syndrome
  • heart failure
  • atrial fibrillation
  • hypertension
  • chronic kidney disease

Research integrates anticoagulant optimization, novel oral agents, and biomarker‑driven risk stratification.

Pulmonary & Respiratory Diseases

Explores innovative treatments for inflammatory and fibrotic lung conditions.

  • severe asthma
  • chronic obstructive pulmonary disease
  • idiopathic pulmonary fibrosis
  • acute respiratory distress syndrome
  • COVID‑19

Focus includes biologic modulators, antifibrotic agents, and strategies to reduce exacerbation frequency.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.